{"id":"W4379330365","doi":"10.1200/jco.2023.41.16_suppl.5502","title":"Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institutes of Health","keywords":"Medicine; Cervical cancer; Clinical endpoint; Cisplatin; Oncology; Ribonucleotide reductase; Internal medicine; Randomized controlled trial; Urology; Brachytherapy; Tolerability; Interim analysis; Cancer; Chemotherapy; Radiation therapy; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002135995,0.001330021,0.001755007,0.0004465728,0.0003747027,0.000978392,0.001091211,0.001683488,0.007008204],"category_scores_gemma":[0.001483086,0.0004610955,0.002018123,0.0005225273,0.0009582096,0.000900804,0.0003547447,0.002655498,0.001058239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009014128,"about_ca_system_score_gemma":0.001527057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001604734,"about_ca_topic_score_gemma":0.00558141,"domain_scores_codex":[0.9994363,0.0003472059,0.00003660829,0.00007013768,0.00003932983,0.00007039372],"domain_scores_gemma":[0.9990844,0.0002213738,0.0002061598,0.00005849912,0.00004571872,0.0003839268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9657295,0.007995999,0.0006660254,0.0006802525,0.0006008809,0.00005717633,0.00006695699,0.0003682663,0.003792634,0.00008543363,0.00106642,0.0188905],"study_design_scores_gemma":[0.9015415,0.09533028,0.001305209,0.00004453387,0.0003950328,0.00005024939,0.00002936474,0.0003105986,0.0003643869,0.0001070447,0.0005076244,0.0000141736],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9812862,0.006308786,0.0005721534,0.001074702,0.000462263,0.006035959,0.001476025,0.0001691782,0.002614874],"genre_scores_gemma":[0.9833224,0.004026566,0.001776116,0.001270821,0.0002855139,0.004245657,0.001714911,0.00003900635,0.00331904],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007008204,"threshold_uncertainty_score":0.02344477,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1088375194101865,"score_gpt":0.4717391893382906,"score_spread":0.3629016699281041,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}